معرفی
Henrik Renlund is a Statistician at UCR-Uppsala Clinical Research center, part of Uppsala University. His work focuses on statistical analysis within medical research, particularly in cardiovascular medicine and registry-based studies. He is actively involved in clinical trials methodology and statistical consultation services.
Dr. Renlund's research interests span multiple domains of medical statistics, with particular emphasis on Biostatistics, Clinical Trials methodology, and Registry Studies. His work demonstrates expertise in analyzing complex cardiovascular datasets, particularly related to anticoagulation therapy in atrial fibrillation patients. He has made significant contributions to understanding the comparative effectiveness of warfarin versus direct oral anticoagulants across various patient populations, including those with chronic kidney disease.
Analysis of his publication record reveals a consistent focus on cardiovascular outcomes research using large-scale registry data from Sweden. His statistical expertise is applied to answer critical clinical questions about anticoagulation therapy, bleeding risks, and optimal treatment strategies for patients with atrial fibrillation and other cardiovascular conditions. The work often involves sophisticated statistical methods for analyzing real-world evidence from national registries.
Dr. Renlund collaborates extensively with clinical researchers across multiple institutions, as evidenced by his numerous co-authored publications in high-impact medical journals including The Lancet, New England Journal of Medicine, and European Heart Journal. His statistical contributions have been instrumental in several major registry-based randomized controlled trials and observational studies in cardiology.
